Join Growin Stock Community!

育世博-KY6976.TW Overview

TW StockBiotech. & Medical
(No presentation for 6976)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

育世博-KY（6976）Overall Performance

育世博-KY（6976）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

育世博-KY（6976） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

育世博-KY（6976）Key Information

育世博-KY（6976）Profile

Acepodia, Inc. operates as a clinical stage biotechnology company. The company engages in developing cell therapies with its unique antibody cell conjugation (ACC) platform technology to address gaps in cancer care. It links tumor targeting antibodies to its proprietary immune cells, such as gamma delta 2 T cells to create novel ACE therapies. The company was founded in 2017 and is headquartered in Grand Cayman, the Cayman Islands.

育世博-KY（6976）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-2.53
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
453.14
PB Ratio
1.41
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
99.31%
Net Margin
-8718.33%
Revenue Growth (YoY)
-%
Profit Growth (YoY)
-%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-2.53
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
453.14
PB Ratio
1.41
Price-to-FCF
-
Gross Margin
99.31%
Net Margin
-8718.33%
Revenue Growth (YoY)
-%
Profit Growth (YoY)
-%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
default symbol

6976

育世博-KY

13.15D

-2.28%

(-0.02)

  • When is 6976's latest earnings report released?

    The most recent financial report for 育世博-KY (6976) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 6976's short-term business performance and financial health. For the latest updates on 6976's earnings releases, visit this page regularly.

  • How much cash does 6976 have?

    At the end of the period, 育世博-KY (6976) held Total Cash and Cash Equivalents of 5.12B, accounting for 0.88 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 6976 go with three margins increasing?

    In the latest report, 育世博-KY (6976) did not achieve the “three margins increasing” benchmark, with a gross margin of 65.41%%, operating margin of -237,310.27%%, and net margin of -183,927.03%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 6976's profit trajectory and future growth potential.